Gasdermin D represses inflammation-induced colon cancer development by regulating apoptosis
Carcinogenesis · 2023
DOI: 10.1093/carcin/bgad005 ↗Kurz gefasst
Fachartikel in der Zeitschrift Carcinogenesis, 2023. Verfasst von Shigekazu Tanaka und 9 weiteren Autor:innen. Beteiligte Einrichtung: Mammalian Genetics Laboratory, Genetic Strains Research Center, National Institute of Genetics, 1111 Yata, Mishima, Shizuoka 411-8540, Japan. Hauptthemen laut MEDLINE: Colonic Neoplasms, Colorectal Neoplasms. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 46 Literaturangaben. Gefördert von: Strategic Research Foundation at Private Universities, Ministry of Education, Culture, Sports, Science and Technology.
Abstract (Originalsprache)
Chronic inflammation is widely recognized as a major risk factor for cancer formation, but the underlying mechanisms are poorly understood. Recently, it was shown that Gasdermin D (GSDMD) protein drives pyroptotic cell death in macrophages on cleavage by inflammatory caspases. Even though the Gsdmd gene is specifically expressed in the intestinal epithelium, the role of Gsdmd in the intestinal tissues remains poorly characterized. In this study, we examined the biological role of Gsdmd in colorectal cancer (CRC) development, employing an azoxymethane/dextran sulfate sodium carcinogenesis model. Results show that GSDMD deficiency enhances CRC development, probably due to decreased apoptosis caused by downregulation of interferon-gamma (IFNγ)—signal transducer and activator 1 (STAT1) signaling. Furthermore, we show that GSDMD protein is diminished in human colorectal cancer, indicating involvement of GSDMD in repression of CRC development in humans. Our findings provide a new insight into functions of Gsdmd/GSDMD in colonic inflammation and human CRC development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Mammalian Genetics Laboratory, Genetic Strains Research Center, National Institute of Genetics, 1111 Yata, Mishima, Shizuoka 411-8540, Japan.
- Shizuoka Medical Research Center for Disaster, Juntendo University, Shizuoka Hospital, 1129 Nagaoka, Izunokuni, Shizuoka 410-2295, Japan.
- Department of Gastroenterology, Juntendo University School of Medicine, 2-1-1 Hongo Bunkyo Ward, Tokyo 113-8421, Japan.
- Department of Pathology, Juntendo University School of Medicine, 2-1-1 Hongo Bunkyo Ward, Tokyo 113-8421, Japan.
- Department of Pathology, Juntendo University Shizuoka Hospital, 1129 Nagaoka, Izunokuni, Shizuoka 410-2295, Japan.
- Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, MD, USA.
ORCID-Profile: Hajime Orita
Förderung
- Strategic Research Foundation at Private Universities
- Ministry of Education, Culture, Sports, Science and Technology
Zitieren
APA
Tanaka, S., Orita, H., Kataoka, T., Miyazaki, M., Saeki, H., Wada, R., Brock, M. V., Fukunaga, T., Amano, T., & Shiroishi, T. (2023). Gasdermin D represses inflammation-induced colon cancer development by regulating apoptosis. Carcinogenesis. https://doi.org/10.1093/carcin/bgad005
Vancouver
Tanaka S, Orita H, Kataoka T, Miyazaki M, Saeki H, Wada R, et al. Gasdermin D represses inflammation-induced colon cancer development by regulating apoptosis. Carcinogenesis. 2023. doi:10.1093/carcin/bgad005
BibTeX
@article{Tanaka2023,
author = {Tanaka, Shigekazu and Orita, Hajime and Kataoka, Taro and Miyazaki, Masahiro and Saeki, Harumi and Wada, Ryo and Brock, Malcolm V and Fukunaga, Tetsu and Amano, Takanori and Shiroishi, Toshihiko},
title = {Gasdermin D represses inflammation-induced colon cancer development by regulating apoptosis},
journal = {Carcinogenesis},
year = {2023},
doi = {10.1093/carcin/bgad005}
}
EUVIMED